Logo image of IVG.MI

IVECO GROUP NV (IVG.MI) Stock Fundamental Analysis

BIT:IVG - Euronext Milan - NL0015000LU4 - Common Stock - Currency: EUR

16.64  -0.07 (-0.45%)

Fundamental Rating

4

Taking everything into account, IVG scores 4 out of 10 in our fundamental rating. IVG was compared to 103 industry peers in the Machinery industry. IVG has only an average score on both its financial health and profitability. IVG has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

In the past year IVG was profitable.
In the past year IVG had a positive cash flow from operations.
IVG had positive earnings in 4 of the past 5 years.
IVG had a positive operating cash flow in each of the past 5 years.
IVG.MI Yearly Net Income VS EBIT VS OCF VS FCFIVG.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

1.2 Ratios

Looking at the Return On Assets, with a value of 1.80%, IVG is doing worse than 60.19% of the companies in the same industry.
The Return On Equity of IVG (12.93%) is better than 76.70% of its industry peers.
Looking at the Return On Invested Capital, with a value of 5.25%, IVG is in line with its industry, outperforming 45.63% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for IVG is below the industry average of 8.83%.
The last Return On Invested Capital (5.25%) for IVG is above the 3 year average (3.91%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 1.8%
ROE 12.93%
ROIC 5.25%
ROA(3y)1.3%
ROA(5y)0.32%
ROE(3y)9.48%
ROE(5y)2.54%
ROIC(3y)3.91%
ROIC(5y)N/A
IVG.MI Yearly ROA, ROE, ROICIVG.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 10 -10

1.3 Margins

IVG has a Profit Margin of 2.28%. This is comparable to the rest of the industry: IVG outperforms 41.75% of its industry peers.
IVG's Profit Margin has improved in the last couple of years.
IVG's Operating Margin of 6.14% is in line compared to the rest of the industry. IVG outperforms 50.49% of its industry peers.
In the last couple of years the Operating Margin of IVG has grown nicely.
Looking at the Gross Margin, with a value of 17.35%, IVG is doing worse than 90.29% of the companies in the same industry.
In the last couple of years the Gross Margin of IVG has grown nicely.
Industry RankSector Rank
OM 6.14%
PM (TTM) 2.28%
GM 17.35%
OM growth 3Y29.77%
OM growth 5Y9.99%
PM growth 3Y77.09%
PM growth 5Y26.56%
GM growth 3Y7.43%
GM growth 5Y4.66%
IVG.MI Yearly Profit, Operating, Gross MarginsIVG.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

More info and screens

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), IVG is destroying value.
Compared to 1 year ago, IVG has less shares outstanding
The number of shares outstanding for IVG has been increased compared to 5 years ago.
IVG has a better debt/assets ratio than last year.
IVG.MI Yearly Shares OutstandingIVG.MI Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
IVG.MI Yearly Total Debt VS Total AssetsIVG.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

Based on the Altman-Z score of 1.78, we must say that IVG is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of IVG (1.78) is comparable to the rest of the industry.
IVG has a debt to FCF ratio of 45.37. This is a negative value and a sign of low solvency as IVG would need 45.37 years to pay back of all of its debts.
The Debt to FCF ratio of IVG (45.37) is worse than 69.90% of its industry peers.
IVG has a Debt/Equity ratio of 1.47. This is a high value indicating a heavy dependency on external financing.
IVG has a Debt to Equity ratio of 1.47. This is amonst the worse of the industry: IVG underperforms 87.38% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.47
Debt/FCF 45.37
Altman-Z 1.78
ROIC/WACC0.76
WACC6.88%
IVG.MI Yearly LT Debt VS Equity VS FCFIVG.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B 5B

2.3 Liquidity

IVG has a Current Ratio of 2.16. This indicates that IVG is financially healthy and has no problem in meeting its short term obligations.
IVG has a better Current ratio (2.16) than 77.67% of its industry peers.
A Quick Ratio of 1.67 indicates that IVG should not have too much problems paying its short term obligations.
The Quick ratio of IVG (1.67) is better than 82.52% of its industry peers.
Industry RankSector Rank
Current Ratio 2.16
Quick Ratio 1.67
IVG.MI Yearly Current Assets VS Current LiabilitesIVG.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

More info and screens

4

3. Growth

3.1 Past

IVG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 13.75%, which is quite good.
The Earnings Per Share has been growing by 32.82% on average over the past years. This is a very strong growth
Looking at the last year, IVG shows a decrease in Revenue. The Revenue has decreased by -7.62% in the last year.
The Revenue has been growing slightly by 5.06% on average over the past years.
EPS 1Y (TTM)13.75%
EPS 3Y88.31%
EPS 5Y32.82%
EPS Q2Q%-45.61%
Revenue 1Y (TTM)-7.62%
Revenue growth 3Y6.52%
Revenue growth 5Y5.06%
Sales Q2Q%-10.13%

3.2 Future

IVG is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.81% yearly.
The Revenue is expected to grow by 3.75% on average over the next years.
EPS Next Y-3.69%
EPS Next 2Y7.38%
EPS Next 3Y10.65%
EPS Next 5Y10.81%
Revenue Next Year0.01%
Revenue Next 2Y2.78%
Revenue Next 3Y4.04%
Revenue Next 5Y3.75%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
IVG.MI Yearly Revenue VS EstimatesIVG.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 5B 10B 15B
IVG.MI Yearly EPS VS EstimatesIVG.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 9.14, the valuation of IVG can be described as very reasonable.
Based on the Price/Earnings ratio, IVG is valued cheaper than 84.47% of the companies in the same industry.
IVG is valuated cheaply when we compare the Price/Earnings ratio to 27.45, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 6.94, the valuation of IVG can be described as very cheap.
Based on the Price/Forward Earnings ratio, IVG is valued cheaper than 93.20% of the companies in the same industry.
IVG is valuated cheaply when we compare the Price/Forward Earnings ratio to 21.90, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 9.14
Fwd PE 6.94
IVG.MI Price Earnings VS Forward Price EarningsIVG.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

IVG's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. IVG is cheaper than 82.52% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, IVG is valued a bit more expensive than the industry average as 60.19% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 32.47
EV/EBITDA 4.57
IVG.MI Per share dataIVG.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0.28
EPS Next 2Y7.38%
EPS Next 3Y10.65%

More info and screens

4

5. Dividend

5.1 Amount

IVG has a Yearly Dividend Yield of 2.09%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 2.93, IVG pays a bit more dividend than its industry peers.
IVG's Dividend Yield is comparable with the S&P500 average which is at 2.42.
Industry RankSector Rank
Dividend Yield 2.09%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

IVG pays out 26.07% of its income as dividend. This is a sustainable payout ratio.
DP26.07%
EPS Next 2Y7.38%
EPS Next 3Y10.65%
IVG.MI Yearly Income VS Free CF VS DividendIVG.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M 600M
IVG.MI Dividend Payout.IVG.MI Dividend Payout, showing the Payout Ratio.IVG.MI Dividend Payout.PayoutRetained Earnings

More info and screens

IVECO GROUP NV

BIT:IVG (7/3/2025, 7:00:00 PM)

16.64

-0.07 (-0.45%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)05-15 2025-05-15/bmo
Earnings (Next)07-30 2025-07-30
Inst Owners41.97%
Inst Owner ChangeN/A
Ins Owners0.1%
Ins Owner ChangeN/A
Market Cap4.51B
Analysts76
Price Target18.27 (9.8%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.09%
Yearly Dividend0.27
Dividend Growth(5Y)N/A
DP26.07%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)35.4%
Min EPS beat(2)7.26%
Max EPS beat(2)63.53%
EPS beat(4)4
Avg EPS beat(4)60.23%
Min EPS beat(4)7.26%
Max EPS beat(4)122.78%
EPS beat(8)5
Avg EPS beat(8)13.96%
EPS beat(12)7
Avg EPS beat(12)6.86%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)5.11%
Min Revenue beat(2)0.94%
Max Revenue beat(2)9.28%
Revenue beat(4)3
Avg Revenue beat(4)1.33%
Min Revenue beat(4)-6.08%
Max Revenue beat(4)9.28%
Revenue beat(8)4
Avg Revenue beat(8)0.27%
Revenue beat(12)8
Avg Revenue beat(12)3.46%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)10.03%
PT rev (3m)9.21%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.56%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-10.02%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.75%
Valuation
Industry RankSector Rank
PE 9.14
Fwd PE 6.94
P/S 0.3
P/FCF 32.47
P/OCF 4.14
P/B 1.67
P/tB 6.84
EV/EBITDA 4.57
EPS(TTM)1.82
EY10.94%
EPS(NY)2.4
Fwd EY14.41%
FCF(TTM)0.51
FCFY3.08%
OCF(TTM)4.02
OCFY24.13%
SpS56.37
BVpS9.95
TBVpS2.43
PEG (NY)N/A
PEG (5Y)0.28
Profitability
Industry RankSector Rank
ROA 1.8%
ROE 12.93%
ROCE 6.94%
ROIC 5.25%
ROICexc 7.02%
ROICexgc 8.78%
OM 6.14%
PM (TTM) 2.28%
GM 17.35%
FCFM 0.91%
ROA(3y)1.3%
ROA(5y)0.32%
ROE(3y)9.48%
ROE(5y)2.54%
ROIC(3y)3.91%
ROIC(5y)N/A
ROICexc(3y)4.85%
ROICexc(5y)N/A
ROICexgc(3y)5.77%
ROICexgc(5y)N/A
ROCE(3y)5.17%
ROCE(5y)N/A
ROICexcg growth 3Y26.65%
ROICexcg growth 5Y12.05%
ROICexc growth 3Y25.45%
ROICexc growth 5Y11.07%
OM growth 3Y29.77%
OM growth 5Y9.99%
PM growth 3Y77.09%
PM growth 5Y26.56%
GM growth 3Y7.43%
GM growth 5Y4.66%
F-Score7
Asset Turnover0.79
Health
Industry RankSector Rank
Debt/Equity 1.47
Debt/FCF 45.37
Debt/EBITDA 2.45
Cap/Depr 140.12%
Cap/Sales 6.21%
Interest Coverage 250
Cash Conversion 67.35%
Profit Quality 39.83%
Current Ratio 2.16
Quick Ratio 1.67
Altman-Z 1.78
F-Score7
WACC6.88%
ROIC/WACC0.76
Cap/Depr(3y)146.94%
Cap/Depr(5y)121.88%
Cap/Sales(3y)5.9%
Cap/Sales(5y)5.2%
Profit Quality(3y)212.1%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)13.75%
EPS 3Y88.31%
EPS 5Y32.82%
EPS Q2Q%-45.61%
EPS Next Y-3.69%
EPS Next 2Y7.38%
EPS Next 3Y10.65%
EPS Next 5Y10.81%
Revenue 1Y (TTM)-7.62%
Revenue growth 3Y6.52%
Revenue growth 5Y5.06%
Sales Q2Q%-10.13%
Revenue Next Year0.01%
Revenue Next 2Y2.78%
Revenue Next 3Y4.04%
Revenue Next 5Y3.75%
EBIT growth 1Y4.22%
EBIT growth 3Y38.23%
EBIT growth 5Y15.55%
EBIT Next Year76.38%
EBIT Next 3Y30.18%
EBIT Next 5YN/A
FCF growth 1Y-62.02%
FCF growth 3YN/A
FCF growth 5Y-8.52%
OCF growth 1Y-18.49%
OCF growth 3Y26.42%
OCF growth 5Y8.96%